These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3212000)

  • 1. Prolactin affects central dopamine receptor function: the behavioral model of aged rats.
    Drago F; Spadaro F; Scapagnini U
    Pharmacol Res Commun; 1988 Dec; 20(12):1101-2. PubMed ID: 3212000
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between dopaminergic control of pituitary lactotroph function and deceleration of age-related changes in serum prolactin of diet-restricted rats.
    Atterwill CK; Brown CG; Conybeare G; Holland CW; Jones CA
    Food Chem Toxicol; 1989 Feb; 27(2):97-103. PubMed ID: 2714721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age related changes in the control of prolactin secretion in the female rat.
    Steger RW
    Neurobiol Aging; 1981; 2(2):119-23. PubMed ID: 7301038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats.
    Drago F; Pulvirenti L; Spadaro F; Pennisi G
    Psychoneuroendocrinology; 1990; 15(5-6):349-56. PubMed ID: 2129310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
    Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
    Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lead treatment affects dopaminergic control of prolactin secretion in rat pituitary.
    Govoni S; Lucchi L; Battaini F; Spano PF; Trabucchi M
    Toxicol Lett; 1984 Mar; 20(3):237-41. PubMed ID: 6701910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of motor behavioural deficits in senescence via chronic prolactin or estrogen administration: time course and putative mechanisms of action.
    Joseph JA; Kochman K; Roth GS
    Brain Res; 1989 Dec; 505(2):195-202. PubMed ID: 2532056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of brain and pituitary dopamine receptors by estrogens and prolactin.
    Di Paolo T; Falardeau P
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):473-80. PubMed ID: 4089182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intrinsic activity of (-)-3-PPP (preclamol) on pituitary DA receptors in female rats is enhanced following chronic DA depletion.
    Carlsson M; Eriksson E
    Life Sci; 1988; 42(5):585-8. PubMed ID: 3339950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective central nervous system dopaminergic function in rats with estrogen-induced pituitary tumors, as assessed by plasma prolactin concentrations.
    Casanueva F; Cocchi D; Locatelli V; Flauto C; Zambotti F; Bestetti G; Rossi GL; Müller E
    Endocrinology; 1982 Feb; 110(2):590-9. PubMed ID: 6799276
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of two dopamine agonists, TL-99 and 3-PPP, on prolactin secretion in the rat.
    Gudelsky GA; Passaro E; Meltzer HY
    Eur J Pharmacol; 1983 Jun; 90(4):423-5. PubMed ID: 6884430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.
    McIntyre IM; Kuhn C; Demitriou S; Fucek FR; Stanley M
    Psychopharmacology (Berl); 1983; 81(2):150-4. PubMed ID: 6415746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels.
    Cebeira M; Hernandez ML; Rodriguez de Fonseca F; de Miguel R; Fernandez-Ruiz JJ; Ramos JA
    Life Sci; 1991; 48(6):531-41. PubMed ID: 1671524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aging on prolactin regulation of rat striatal dopamine receptor concentrations.
    Levin P; Haji M; Joseph JA; Roth GS
    Life Sci; 1983 Apr; 32(15):1743-9. PubMed ID: 6835021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in the regulation of behavior by D-1:D-2 dopamine receptor interactions.
    Murray AM; Waddington JL
    Neurobiol Aging; 1991; 12(5):431-5. PubMed ID: 1837593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland.
    Mikuni M; Gudelsky GA; Simonovic M; Meltzer HY
    Life Sci; 1984 Jan; 34(3):239-46. PubMed ID: 6694521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin levels in male and female rats perinatally treated with bromopride.
    Felicio LF; Miranda WL; Nasello AG
    Braz J Med Biol Res; 1988; 21(1):133-6. PubMed ID: 3179568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of lithium treatment on the activity of central dopaminergic neurons].
    Koyama T
    Hokkaido Igaku Zasshi; 1987 May; 62(3):402-16. PubMed ID: 3111963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A permanent dopamine receptor up-regulation in the ovariectomized rat.
    Gordon JH; Fields JZ
    Pharmacol Biochem Behav; 1989 May; 33(1):123-5. PubMed ID: 2780771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
    Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
    Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.